Blocking core fucosylation of TGF-β1 receptors downregulates their functions and attenuates the epithelial-mesenchymal transition of renal tubular cells

American Journal of Physiology - Renal Physiology

Volumn 300, Issue 4, 2011, Pages 1017-1025

  Lin, Hongli ^a   Wang, Dapeng ^a   Wu, Taihua ^b   Dong, Cui ^a   Shen, Nan ^a   Sun, Yuan ^a   Sun, Yanling ^a   Xie, Hua ^a   Wang, Nan ^a   Shan, Lujuan ^b  

^a Department of Nephrology ^*  (China)

^b DALIAN MEDICAL UNIVERSITY   (China)

Author keywords

6 fucosyltransferase; A 1; Renal fibrosis; Renal tubular epithelial

Indexed keywords

ALPHA 1,6 FUCOSYLTRANSFERASE; FUCOSYLTRANSFERASE; SMAD2 PROTEIN; SMAD3 PROTEIN; SMALL INTERFERING RNA; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 1; TRANSFORMING GROWTH FACTOR BETA RECEPTOR 2; TRANSFORMING GROWTH FACTOR BETA1; UNCLASSIFIED DRUG;

ARTICLE; CONTROLLED STUDY; DOWN REGULATION; EPITHELIAL MESENCHYMAL TRANSITION; FUCOSYLATION; HUMAN; HUMAN CELL; KIDNEY TUBULE CELL; MOLECULAR MODEL; PRIORITY JOURNAL; PROTEIN EXPRESSION; PROTEIN FUNCTION; PROTEIN PHOSPHORYLATION; SIGNAL TRANSDUCTION;

EID: 79954546159     PISSN: 1931857X     EISSN: 15221466     Source Type: Journal    
DOI: 10.1152/ajprenal.00426.2010     Document Type: Article

References (38)

1. Border WA, Noble NA. Transforming growth factor beta in tissue fibrosis. N Engl J Med 331: 1286-1292, 1994.
2. Border WA, Noble NA, Yamamoto T, Harper JR, Yamaguchi Y, Pierschbacher MD, Ruoslahti E. Natural inhibitor of transforming growth factor-p protects against scarring in experimental kidney disease. Nature 360: 361-364, 1992.
3. Bottinger EP, Bitzer M. TGF-fj signaling in renal disease. J Am Soc Nephrol 13: 2600-2610, 2002.
4. Burns WC, Kantharidis P, Thomas MC. The role of tubular epithelial-mesenchymal transition in progressive kidney disease. Cells Tissues Organs 185: 222-223, 2007.
5. Dwek RA. Glycobiology: "towards understanding the function of sugars." Biochem Soc Trans 23: 1-25, 1995.
6. Fan JM, Ng YY, Hill PA, Nikolic-Paterson DJ, Mu W, Atkins RC, Lan HY. Transforming growth factor- fj regulates tubular epithelial-myofibro-blast transdifferentiation in vitro. Kidney Int 56: 1455-1467, 1999.
7. Goldman R, Ressom HW, Varghese RS, Goldman L, Bascug G, Loffredo CA, Abdel-Hamid M, Gouda I, Ezzat S, Kyselova Z, Mechref Y, Novotny MV. Detection of hepatocellular carcinoma using glycomic analysis. Clin Cancer Res 15: 1808-1813, 2009.
8. Hakomori S. Glycosylation defining cancer malignancy: new wine in an old bottle. Proc Natl Acad Sci USA 99: 10231-10233, 2002.
9. Han DC, Hoffman BB, Hong SW, Guo J, Ziyadeh FN. Therapy with antisense TGF-fj1 oligodeoxynucleotides reduces kidney weight and matrix mRNAs in diabetic mice. Am J Physiol Renal Physiol 278: F628-F634, 2000.
10. Hong SW, Isono M, Chen S, Iglesiasde la Cruz MC, Han DC, Ziyadeh FN. Increased glomerular and tubular expression of transforming growth factor-31, its type II receptor, and activation of the Smad signaling pathway in the db/db mouse. Am J Pathol 158: 1653-1663, 2001.
11. Hu P, Shi B, Geng F, Zhang C, Wu W, Wu XZ. E-cadherin core fucosylation regulates nuclear beta-catenin accumulation in lung cancer cells. Glycoconj J 25: 843-850, 2008.
12. Iwano M, Neilson EG. Mechanisms of tubulointerstitial fibrosis. Curr Opin Nephrol Hypertens 13: 279-284, 2004.
13. Kondo A. Identification of target proteins of glycosyltransferases using functional glycomics by gene expression regulation. Trends Glycosci Glycotechnol 19: 247-256, 2007.
14. Logue CA, Peak IR, Beacham IR. Facile construction of unmarked deletion mutants in Burkholderia pseudomallei using sacB counter-selection in sucrose-resistant and sucrose-sensitive isolates. J Microbiol Methods 76: 320-323, 2009.
15. Matsumoto K, Shimizu C, Arao T, Andoh M, Katsumata N, Kohno T, Yonemori K, Koizumi F, Yokote H, Aogi K, Tamura K, Nishio K, Fujiwara Y. Identification of predictive biomarkers for response to trastuzumab using plasma FUCA activity and N-glycan identified by MALDI-TOF-MS. J Proteome Res 8: 457-462, 2009.
16. Matsumoto K, Yokote H, Arao T, Maegawa M, Tanaka K, Fujita Y, Shimizu C, Hanafusa T, Fujiwara Y, Nishio K. N-glycan fucosylation of epidermal growth factor receptor modulates receptor activity and sensitivity to epidermal growth factor receptor tyrosine kinase inhibitor. Cancer Sci 99: 1611-1617, 2008.
17. Nakamura T, Miller D, Ruoslahti E, Border WA. Production of extracellular matrix by glomerular epithelial cells is regulated by transforming growth factor-31. Kidney Int 41: 1213-1221, 1992.
18. Newsom-Davis TE, Wang D, Steinman L, Chen PF, Wang LX, Simon AK, Screaton GR. Enhanced immune recognition of cryptic glycan markers in human tumors. Cancer Res 69: 2018-2025, 2009.
19. Ohtsubo K, Marth JD. Glycosylation in cellular mechanisms of health and disease. Cell 126: 855-867, 2006.
20. Okazaki Y, Yamasaki Y, Uchida HA, Okamoto K, Satoh M, Maruyama K, Maeshima Y, Sugiyama H, Sugaya T, Kashihara N, Makino H. Enhanced TGF-beta/Smad signaling in the early stage of diabetic nephropathy is independent of the AT1 a receptor. Clin Exp Nephrol 11: 77-87, 2007.
21. Osumi D, Takahashi M, Miyoshi E, Yokoe S, Lee SH, Noda K, Nakamori S, Gu J, Ikeda Y, Kuroki Y, Sengoku K, Ishikawa M, Taniguchi N. Core fucosylation of E-cadherin enhances cell-cell adhesion in human colon carcinoma WiDr cells. Cancer Sci 100: 888-895, 2009.
22. Phanish MK, Wahab NA, Colville-Nash P, Hendry BM, Dockrell MEC. The differential role of Smad2 and Smad3 in the regulation of pro-fibrotic TGFfj1 responses in human proximal-tubule epithelial cells. Biochem J 393: 601-607, 2006.
23. Sato M, Muragaki Y, Saika S, Roberts AB, Ooshima A. Targeted disruption of TGF-fj1/Smad3 signaling protects against renal tubulointerstitial fibrosis induced by unilateral ureteral obstruction. J Clin Invest 112: 1486-1494, 2003.
24. Saxon E, Bertozzi CR. Chemical and biological strategies for engineering cell surface glycosylation. Annu Rev Cell Dev Biol 17: 1-23, 2001.
25. Schutzbach J, Brockhausen I. Inhibition of glycosyltransferase activities as the basis for drug development. Methods Mol Biol 534: 359-373, 2009.
26. Sharma K, Jin Y, Guo J, Ziyadeh FN. Neutralization of TGF-beta by anti-TGF-beta antibody attenuates kidney hypertrophy and the enhanced extracellular matrix gene expression in STZ-induced diabetic mice. Diabetes 45: 522-530, 1996.
27. Strutz F, Muller GA. On the progression of chronic disease. Nephron 69: 371-379, 1995.
28. Sulová Z, Mislovicová D, Gibalová L, Vajcnerová Z, Poláková E, Uhrík B, Tylková L, Kovarova A, Sedlák J, Breier A. Vincristine-induced overexpression of P-glycoprotein in L1210 cells is associated with remodeling of cell surface saccharides. J Proteome Res 8: 513-520, 2009.
29. Takahashi M, Kuroki Y, Ohtsubo K, Taniguchi N. Core fucose and bisecting GlcNAc, the direct modifiers of the N-glycan core: their functions and target proteins. Carbohydr Res 344: 1387-1390, 2009.
30. Taniguchi N, Ekuni A, Ko JH, Miyoshi E, Ikeda Y, Ihara Y, Ni-shikawa A, Honke K, Takahashi M. A glycomic approach to the identification and characterization of glycoprotein function in cells trans-fected with glycosyltransferase genes. Proteomics 1: 239-247, 2001.
31. Taniguchi N, Hancock W, Lubman DM, Rudd PM. The second golden age of glycomics: from functional glycomics to clinical applications. J Proteome Res 8: 425-426, 2009.
32. Uozumi N, Yanagidani S, Miyoshi E, Ihara Y, Sakuma T, Gao CX, Teshima T, Fujii S, Shiba T, Taniguchi N. Purification and cDNA cloning of porcine brain GDP-L-Fuc:N-acetyl-beta-D-glucosaminide alpha1^6fucosyltransferase. J Biol Chem 271: 27810-27817, 1996.
33. Varki A. Biological roles of oligosaccharides: all of the theories are correct. Glycobiology 3: 97-130, 1993.
34. Wang X, Inoue S, Gu J, Miyoshi E, Noda K, Li W, Mizuno-Horikawa Y, Nakano M, Asahi M, Takahashi M, Uozumi N, Ihara S, Lee SH, Ikeda Y, Yamaguchi Y, Aze Y, Tomiyama Y, Fujii J, Suzuki K, Kondo A, Shapiro SD, Lopez-Otin C, Kuwaki T, Okabe M, Honke K, Taniguchi N. Dysregulation of TGF-beta1 receptor activation leads to abnormal lung development and emphysema-like phenotype in core fu-cose-deficient mice. Proc Natl Acad Sci USA 102: 15791-15796, 2005.
35. Yanagidani S, Uozumi N, Ihara Y, Miyoshi E, Yamaguchi N, Taniguchi N. Purification and cDNA cloning of GDP-L-Fuc:N-acetyl-beta-D-glucosaminide alpha1^6fucosyltransferase-1-6 FucT) from human gastric cancer MKN45 cells. J Biochem 121: 626-632, 1997.
36. Zhao Y, Itoh S, Wang X, Isaji T, Miyoshi E, Kariya Y, Miyazaki K, Kawasaki N, Taniguchi N, Gu J. Deletion of core fucosylation onaalpha3beta1 integrin down-regulates its functions. J Biol Chem 281: 38343-38350, 2006.
37. Zhao YY, Takahashi M, Gu JG, Miyoshi E, Matsumoto A, Kitazume S, Taniguchi N. Functional roles of N-glycans in cell signaling and cell adhesion in cancer. Cancer Sci 99: 1304-1310, 2008.
38. Ziyadeh FN, Hoffman BB, Han DC, Iglesiasde la Cruz MC, Hong SW, Isono M, Chen S, McGowan TA, Sharma K. Long-term prevention of renal insufficiency, excess matrix gene expression, and glomerular mesangial matrix expansion by treatment with monoclonal antitransform-ing growth factor- fj antibody in db/db diabetic mice. Proc Natl Acad Sci USA 97: 8015-8020, 2000.